Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022

Author: Benzinga Insights | December 22, 2022 11:00am

Upgrades

According to DA Davidson, the prior rating for Helen Of Troy Ltd (NASDAQ:HELE) was changed from Neutral to Buy. Helen Of Troy earned $2.27 in the second quarter, compared to $2.65 in the year-ago quarter. The current stock performance of Helen Of Troy shows a 52-week-high of $249.08 and a 52-week-low of $82.94. Moreover, at the end of the last trading period, the closing price was at $97.25.

See all analyst ratings upgrades.

Downgrades

For Nkarta Inc (NASDAQ:NKTX), Oppenheimer downgraded the previous rating of Outperform to Perform. In the third quarter, Nkarta showed an EPS of $0.58, compared to $0.68 from the year-ago quarter. The stock has a 52-week-high of $20.35 and a 52-week-low of $5.81. At the end of the last trading period, Nkarta closed at $5.88.

Oppenheimer downgraded the previous rating for Fate Therapeutics Inc (NASDAQ:FATE) from Outperform to Perform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $66.56 and a 52-week-low of $12.15. Moreover, at the end of the last trading period, the closing price was at $12.25.

For Celularity Inc (NASDAQ:CELU), Oppenheimer downgraded the previous rating of Outperform to Perform. Celularity earned $0.03 in the third quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.19 and a 52-week-low of $1.10. Celularity closed at $1.28 at the end of the last trading period.

According to Keefe, Bruyette & Woods, the prior rating for Jefferies Financial Group Inc (NYSE:JEF) was changed from Outperform to Market Perform. For the third quarter, Jefferies Financial Group had an EPS of $1.10, compared to year-ago quarter EPS of $1.50. The stock has a 52-week-high of $41.49 and a 52-week-low of $25.88. At the end of the last trading period, Jefferies Financial Group closed at $35.67.

Canaccord Genuity downgraded the previous rating for Coupa Software Inc (NASDAQ:COUP) from Buy to Hold. In the third quarter, Coupa Software showed an EPS of $0.15, compared to $0.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $166.21 and a 52-week-low of $40.30. Coupa Software closed at $78.59 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

EF Hutton initiated coverage on Golden Matrix Group Inc (NASDAQ:GMGI) with a Buy rating. The price target for Golden Matrix Group is set to $3.00. For the third quarter, Golden Matrix Group had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $10.72 and a 52-week-low of $1.89. At the end of the last trading period, Golden Matrix Group closed at $2.25.

With a Buy rating, Mizuho initiated coverage on The Cooper Companies Inc (NYSE:COO). The price target seems to have been set at $375.00 for Cooper Companies. Cooper Companies earned $2.75 in the fourth quarter, compared to $3.28 in the year-ago quarter. The stock has a 52-week-high of $430.67 and a 52-week-low of $244.22. At the end of the last trading period, Cooper Companies closed at $328.69.

With a Neutral rating, Mizuho initiated coverage on Glaukos Corp (NYSE:GKOS). The price target seems to have been set at $48.00 for Glaukos. In the third quarter, Glaukos showed an EPS of $0.45, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $64.49 and a 52-week-low of $33.33. At the end of the last trading period, Glaukos closed at $43.58.

Mizuho initiated coverage on Boston Scientific Corp (NYSE:BSX) with a Neutral rating. The price target for Boston Scientific is set to $52.00. Boston Scientific earned $0.43 in the third quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.95 and a 52-week-low of $34.98. Boston Scientific closed at $46.08 at the end of the last trading period.

Scotiabank initiated coverage on Ivanhoe Electric Inc (AMEX:IE) with a Sector Perform rating. The price target for Ivanhoe Electric is set to $14.00. The stock has a 52-week-high of $15.53 and a 52-week-low of $7.01. At the end of the last trading period, Ivanhoe Electric closed at $12.40.

With a Buy rating, Mizuho initiated coverage on Alcon Inc (NYSE:ALC). The price target seems to have been set at $85.00 for Alcon. In the third quarter, Alcon showed an EPS of $0.50, compared to $0.54 from the year-ago quarter. The current stock performance of Alcon shows a 52-week-high of $88.78 and a 52-week-low of $55.21. Moreover, at the end of the last trading period, the closing price was at $68.28.

Cantor Fitzgerald initiated coverage on Oncternal Therapeutics Inc (NASDAQ:ONCT) with an Overweight rating. The price target for Oncternal Therapeutics is set to $4.00. In the third quarter, Oncternal Therapeutics showed an EPS of $0.21, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $2.72 and a 52-week-low of $0.69. At the end of the last trading period, Oncternal Therapeutics closed at $0.88.

Janney Montgomery Scott initiated coverage on Markel Corp (NYSE:MKL) with a Buy rating. The price target for Markel is set to $1550.00. Markel earned $24.20 in the third quarter, compared to $15.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1519.24 and a 52-week-low of $1064.09. Markel closed at $1290.30 at the end of the last trading period.

With an Overweight rating, Cantor Fitzgerald initiated coverage on X4 Pharmaceuticals Inc (NASDAQ:XFOR). The price target seems to have been set at $3.00 for X4 Pharmaceuticals. X4 Pharmaceuticals earned $0.26 in the third quarter, compared to $0.76 in the year-ago quarter. The current stock performance of X4 Pharmaceuticals shows a 52-week-high of $2.68 and a 52-week-low of $0.65. Moreover, at the end of the last trading period, the closing price was at $0.80.

With a Buy rating, HC Wainwright & Co. initiated coverage on Applied Digital Corp (NASDAQ:APLD). The price target seems to have been set at $4.00 for Applied Digital. For the first quarter, Applied Digital had an EPS of $0.04, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $28.08 and a 52-week-low of $0.85. Applied Digital closed at $1.71 at the end of the last trading period.

Loop Capital initiated coverage on Procore Technologies Inc (NYSE:PCOR) with a Buy rating. The price target for Procore Technologies is set to $70.00. Procore Technologies earned $0.09 in the third quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $83.70 and a 52-week-low of $40.00. At the end of the last trading period, Procore Technologies closed at $49.63.

With a Neutral rating, Baird initiated coverage on Parsons Corp (NYSE:PSN). The price target seems to have been set at $50.00 for Parsons Corp. Parsons Corp earned $0.48 in the third quarter, compared to $0.44 in the year-ago quarter. The current stock performance of Parsons Corp shows a 52-week-high of $50.15 and a 52-week-low of $29.25. Moreover, at the end of the last trading period, the closing price was at $46.54.

Evercore ISI Group initiated coverage on Global Business Travel Group Inc (NYSE:GBTG) with an Outperform rating. The price target for Global Business Travel is set to $8.00. The current stock performance of Global Business Travel shows a 52-week-high of $9.28 and a 52-week-low of $4.26. Moreover, at the end of the last trading period, the closing price was at $6.30.

With an Outperform rating, RBC Capital initiated coverage on Brookfield Asset Management Ltd (NYSE:BAM). The price target seems to have been set at $35.00 for Brookfield Asset Mgmt. In the third quarter, Brookfield Asset Mgmt showed an EPS of $0.24, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $62.47 and a 52-week-low of $26.76. At the end of the last trading period, Brookfield Asset Mgmt closed at $28.20.

With an Outperform rating, Wedbush initiated coverage on Getty Images Holdings Inc (NYSE:GETY). The price target seems to have been set at $6.00 for Getty Images Holdings. The current stock performance of Getty Images Holdings shows a 52-week-high of $37.88 and a 52-week-low of $4.51. Moreover, at the end of the last trading period, the closing price was at $5.06.

With a Buy rating, EF Hutton initiated coverage on Agenus Inc (NASDAQ:AGEN). The price target seems to have been set at $8.30 for Agenus. For the third quarter, Agenus had an EPS of $0.19, compared to year-ago quarter EPS of $0.72. The current stock performance of Agenus shows a 52-week-high of $3.62 and a 52-week-low of $1.25. Moreover, at the end of the last trading period, the closing price was at $2.44.

See all analyst ratings initiations.

Posted In: AGEN ALC APLD BAM BSX CELU COO COUP FATE GBTG GETY GKOS GMGI HELE IE JEF MKL NKTX ONCT PCOR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist